Cellestia Biotech
Cellestia develops targeted therapies for cancer patients with no other options, including orphan cancers and childhood leukemia.
15 employees · est. 2014 · Basel, Switzerland
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
9 employees · est. 2012 · Edmonton, Canada
Pacylex Pharmaceuticals, Inc. is the older company (2014 vs 2012); Cellestia Biotech is the larger of the two.
Side-by-Side Comparison
| Metric | Cellestia Biotech | Pacylex Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2012 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Edmonton, Canada |
| Employees | ||
| Employees | 15 larger | 9 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Non Equity Assistance | Grant |
| Total Funding | ||
| Total Funding | $48.17M | $12.30M |
| Funding Rounds | ||
| Funding Rounds | 10 | 5 |
| Services | ||
| Services | Not tracked yet | Development of first-in-class NMT-inhibitor therapeutics, Clinical trials for zelenirstat, Partnership for ADC development |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer Patients, Pharmaceutical Companies, Clinical Researchers, Investors in Oncology |
| Taxonomy | ||
| Taxonomy | Biotech, Cancer Therapy, Targeted Therapies, Orphan Cancers, Childhood Leukemia, Autoimmune Diseases, Multi-drug Resistant Cancers, Clinical Stage Drug Candidate, CB-103, Proof-of-Concept Clinical Study, GvHD, Innovative Therapeutics, Novel Modes Of Action, IITs, Biological Activity | Cancer Therapy, Oncology, Clinical Stage Company, Small Molecule Drugs, Solid Tumors, Blood Cancers, Phase 1 Clinical Trial, Refractory Cancer, Combination Therapy, N-myristoylation Inhibitor, Drug Resistance, Bioavailability, MD Anderson, Phase 2 Study, AML |
| Website | ||
| Website | cellestia.com | pacylex.com |
About Cellestia Biotech
Cellestia Biotech is a Swiss-based biopharma startup founded in 2014. The company's mission is to develop targeted therapies for cancer patients with no other options, with a focus on orphan cancers and childhood leukemia. Their flagship drug candidate, CB-103, has shown promising results in terms o...
About Pacylex Pharmaceuticals, Inc.
Pacylex Pharmaceuticals, Inc., founded in 2012 and headquartered in Canada, is a clinical-stage company at the forefront of cancer treatment innovation. With the slogan, "A new target in cancer care - triggering selective lethality with a new class of drugs," the company focuses on developing PCLX-0...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Cellestia Biotech and Pacylex Pharmaceuticals, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Cellestia Biotech and Pacylex Pharmaceutical... — by email.
Frequently Asked Questions
Compare Cellestia Biotech with someone else
Start typing a company name or domain.